A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZhujiang Hospital
About this trial
By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
Age: over 18 years old;
There are sufficient remaining serum samples and extensive informed consent has been signed.
Disqualifiers
Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases；
Improper storage or repeated freeze-thaw of remaining serum samples.
Trial population
Patients over 18 years old attending the outpatient/emergency/inpatient departments of Zhujiang Hospital, including departments such as hematology, general surgery, dermatology, and others.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 1 trial groupGroup A: Patients who come to the hospital for treatment
Trial outcomes
Primary outcomes
1
Positive rate of M protein
Positive rate of serum M protein in patients seeking medical treatment at the hospital
Time frame
one year2
The distribution of positive rate of M protein in different departments
The positive rate of serum M protein in the patients visiting the hospital and its distribution in different departments.
Time frame
one yearSecondary outcomes
1
Correlation analysis
Correlation analysis between the relative concentration of serum M protein and clinical indicators.
Time frame
one yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov